Administration occupational activities – Page 3

Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings

3 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Chronic disease, Confirmation, Hearings, public health policy, Robert F. Kennedy, Secretary Nomination, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., HHS Secretary nomination, Senate confirmation hearings, vaccine skepticism, chronic disease focus, public health policy, Trump administration

Tris Pharma’s Cebranopadol Shows Promising Results in Phase 3 Trial for Moderate-to-Severe Acute Pain Treatment

3 months ago talkbio0Tagged Acute onset pain, Administration occupational activities, Agonist, ALLEVIATE-1, Cebranopadol, Clinical Trials, Dual-NMR, Opioid Crisis, Pain, Phase 3, Tris Pharma

Cebranopadol, Tris Pharma, ALLEVIATE-1, Phase 3 Clinical Trial, Acute Pain Treatment, Dual-NMR Agonist, Opioid Crisis, Pain Management

Trump Revokes Biden’s Executive Order on AI Safety and Trustworthiness

3 months ago talkbio0Tagged Administration occupational activities, AI safety, Aortic Valve Insufficiency, Artificial (qualifier value), Biden Executive Order, governance, Regulation, Transplant Registry Unified Management Program

AI Safety, Biden Executive Order, Trump Administration, Artificial Intelligence Governance, AI Regulation

Understanding the Second Round of Medicare Drug Price Negotiations: What Trump’s CMS Can and Can’t Change

3 months ago talkbio0Tagged Administration occupational activities, CMS, drug price, Inflation, Medicare, Myasthenic Syndromes, Congenital, negotiation, Prices, Transplant Registry Unified Management Program

Medicare drug price negotiation, Trump administration, CMS, Inflation Reduction Act, drug prices, negotiation process

Trump’s Re-Election: A Mixed Bag for Biopharma with M&A Upsides and Vaccine Concerns

5 months ago talkbio0Tagged Acquisitions, Administration occupational activities, Biopharma, Independence, Inflation, mergers, Policy, Transplant Registry Unified Management Program, United States Food and Drug Administration, Vaccines

Trump Administration, Biopharma, Mergers and Acquisitions, Vaccine Policy, Robert F. Kennedy Jr., FDA Independence, Inflation Reduction Act

Controversial Stanford Professor Jay Bhattacharya Nominated by Trump to Lead NIH Amid Criticism Over Pandemic Views

5 months ago talkbio0Tagged Administration occupational activities, Appointments, Bhattacharya, Controversial, COVID19 (disease), Critic, Jay, NIH Director Nomination, Pandemic Response, Professor, Public Health Research, Stanford University, Transplant Registry Unified Management Program

Jay Bhattacharya, NIH Director Nomination, COVID-19 Pandemic Response Critic, Stanford University Professor, Trump Administration, Public Health Research, Controversial Appointment